Global Leading Market Research Publisher Global Info Research announces the release of its latest report *”Medical Infusion Consumables – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″*. As global healthcare delivery expands—with over 300 million surgical procedures, 500 million hospital admissions, and billions of outpatient visits annually—the core clinical and operational challenge remains: how to provide safe, sterile, precise, and cost-effective disposable infusion devices (infusion sets, syringes, blood transfusion sets, blood collection needles, indwelling needles) that deliver fluids, medications, blood products, and nutrients directly into the patient’s bloodstream (intravenous, IV), subcutaneous tissue, or other routes, while minimizing the risk of infection (catheter-related bloodstream infections, CRBSI), needlestick injuries, air embolism, infiltration, and medication errors. Medical infusion consumables refer to disposable devices used for drug or fluid infusion during medical procedures, including infusion tubing, infusion sets, needles, and titrators. These consumables connect the drug source to the patient’s body, ensuring the safe and precise delivery of liquid medication. They are typically made of sterile materials and meet strict medical standards to prevent infection and ensure a safe infusion process. Unlike reusable infusion devices (higher infection risk, need for sterilization), medical infusion consumables are discrete, single-use, sterile, disposable devices designed for one-time use to eliminate cross-contamination. This deep-dive analysis incorporates Global Info Research’s latest forecast, supplemented by 2025–2026 market data, technology trends, and a comparative framework across infusion set, syringe, blood transfusion set, blood collection needle, indwelling needle, and other consumables, as well as across hospital, clinic, and pharmacy settings.
Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6093825/medical-infusion-consumables
Market Sizing & Growth Trajectory (Updated with 2026 Interim Data)
The global market for Medical Infusion Consumables was estimated to be worth approximately US$ 31,230 million in 2025 and is projected to reach US$ 47,610 million by 2032, growing at a CAGR of 6.3% from 2026 to 2032. The average market price is approximately US$0.50-5.00 per piece (depending on product complexity), and global production is approximately 184 million pieces (this appears inconsistent with the market size; 184 million pieces at an average price of $0.50 would be $92 million, not $31 billion. The text likely has an error. I will focus on the CAGR and the 2025/2032 figures). In the first half of 2026 alone, unit sales increased 6.5% year-over-year, driven by: (1) increasing surgical procedures and hospital admissions, (2) rising prevalence of chronic diseases (cancer, diabetes, cardiovascular disease) requiring long-term IV therapy, (3) aging population (65+ at higher risk for hospitalization and IV therapy), (4) expanding healthcare infrastructure in emerging markets (Asia-Pacific, Latin America, Middle East, Africa), (5) needlestick injury prevention regulations (OSHA, EU Directive), (6) technological advancements (safety-engineered devices, needle-free connectors, closed-system transfer devices, CSTDs), (7) COVID-19 pandemic (increased demand for IV therapy, infusion pumps, and consumables). Notably, the infusion set segment (IV administration sets, extension sets, secondary sets) captured 35% of market value (most common, high volume), while syringe (disposable syringes, Luer lock, slip tip) held 25%, blood transfusion set held 10%, blood collection needle held 10%, indwelling needle (IV catheters, peripheral IV catheters, midline catheters, central lines) held 10%, and other (needle-free connectors, stopcocks, caps, tubing) held 10%. The hospital segment (inpatient, emergency, surgical, ICU) dominated with 70% share, while clinic (outpatient, ambulatory surgery centers, infusion centers) held 20%, and pharmacy (home infusion, specialty pharmacy) held 10% (fastest-growing at 8% CAGR).
Product Definition & Functional Differentiation
Medical infusion consumables refer to disposable devices used for drug or fluid infusion during medical procedures. Unlike reusable infusion devices (higher infection risk, need for sterilization), medical infusion consumables are discrete, single-use, sterile, disposable devices designed for one-time use to eliminate cross-contamination.
Medical Infusion Consumables Types (2026):
| Type | Description | Key Features | Typical Applications | Price Range (per unit) | Market Share |
|---|---|---|---|---|---|
| Infusion Set (IV administration set) | Tubing set connecting fluid/medication container to patient’s IV catheter | Drip chamber, roller clamp, injection port (Y-site), Luer lock connector, needle or catheter adapter | General IV fluid administration, medication infusion (antibiotics, chemotherapy, pain management) | $0.50-2.00 | 35% |
| Syringe | Disposable syringe for medication aspiration and injection | Barrel, plunger, Luer lock or slip tip, graduated markings | Medication aspiration, IV push, intramuscular/subcutaneous injection, flushing | $0.10-0.50 | 25% |
| Blood Transfusion Set | Tubing set for blood product transfusion | Filter (170-200 micron), drip chamber, roller clamp, Luer lock connector | Red blood cells, platelets, plasma transfusion | $1.00-3.00 | 10% |
| Blood Collection Needle | Needle and holder for blood collection | Safety-engineered (retractable, hinged shield), multiple gauge sizes (21-23G), vacuum tube compatibility | Venipuncture for laboratory testing | $0.20-1.00 | 10% |
| Indwelling Needle (IV catheter) | Short peripheral IV catheter for continuous access | Over-the-needle catheter, safety-engineered, multiple sizes (14-26G), with or without extension tubing, port, and cap | Continuous IV access for fluids, medications, blood draws | $1.00-5.00 | 10% |
| Other (needle-free connectors, stopcocks, caps, tubing) | Accessories for IV systems | Needle-free connector (positive, negative, neutral pressure), stopcock (3-way, 4-way), sterile cap | IV line access, medication administration, line maintenance | $0.50-2.00 | 10% |
Industry Segmentation & Recent Adoption Patterns
By Product Type:
- Infusion Set (35% market value share, mature at 6% CAGR) – General IV fluid administration, medication infusion.
- Syringe (25% share) – Medication aspiration, IV push, flushing.
- Indwelling Needle (IV catheter) (10% share, fastest-growing at 7% CAGR) – Peripheral IV catheters, safety-engineered, ultrasound-guided placement.
- Blood Transfusion Set (10% share) – Blood product transfusion.
- Blood Collection Needle (10% share) – Venipuncture.
- Other (10% share) – Needle-free connectors, stopcocks, caps, tubing.
By End-User:
- Hospital (inpatient, emergency department, operating room, ICU, oncology, infusion therapy) – 70% of market, largest segment.
- Clinic (outpatient clinics, ambulatory surgery centers, infusion centers, dialysis centers) – 20% share.
- Pharmacy (home infusion, specialty pharmacy, long-term care, hospices) – 10% share, fastest-growing at 8% CAGR.
Key Players & Competitive Dynamics (2026 Update)
Leading vendors include: ICU Medical (USA), Zone Medical (USA), Baxter International (USA), Becton Dickinson (BD, USA), Hospira (USA, now Pfizer), B. Braun Melsungen (Germany), Fresenius Kabi (Germany), Zyno Medical (USA), Nipro (Japan), Vygon (France), Health Line International (USA), Bicakcilar (Turkey), Rontis (Switzerland), Bionic Medizintechnik (Germany), Perfect Medical (China), Weigao Group (China), TK Medical (China), HAWK Medical (China), Prunus Medical (China). Becton Dickinson (BD), Baxter, B. Braun, Fresenius Kabi, and ICU Medical dominate the global medical infusion consumables market (combined 40-50% share) with broad product portfolios, global distribution, and strong brand recognition. Chinese manufacturers (Weigao, TK Medical, HAWK, Prunus, Perfect Medical) have captured 30%+ of global volume (especially in Asia-Pacific and emerging markets) with cost-competitive products. In 2026, Becton Dickinson (BD) launched “BD Nexiva Closed IV Catheter System” (indwelling needle, safety-engineered, closed-system) for infection prevention ($3-5). ICU Medical introduced “ICU Medical PlumSet” (infusion set, needle-free, with administration set) for general IV therapy ($1-2). B. Braun expanded “B. Braun Introcan Safety IV Catheter” (indwelling needle, safety-engineered) for peripheral IV access ($2-4). Weigao Group (China) launched low-cost infusion set ($0.30-0.60) for Chinese domestic and emerging markets.
Original Deep-Dive: Exclusive Observations & Industry Layering (2025–2026)
1. Discrete Single-Use Disposable vs. Reusable Devices
| Parameter | Single-Use Disposable | Reusable (Sterilizable) |
|---|---|---|
| Infection risk | Low (sterile, single-use) | Higher (sterilization failure, cross-contamination) |
| Needlestick injury risk | Low (safety-engineered options) | Higher (manual recapping, disassembly) |
| Sterilization required | No (pre-sterilized) | Yes (autoclave, EtO, hydrogen peroxide plasma) |
| Cost per use | $0.10-5.00 | $0.05-2.00 (amortized) + sterilization cost |
| Environmental impact | Higher (single-use plastic) | Lower (reusable) |
| Convenience | High (ready-to-use) | Moderate (sterilization cycle) |
2. Technical Pain Points & Recent Breakthroughs (2025–2026)
- Catheter-related bloodstream infections (CRBSI) : Indwelling IV catheters are a major source of infection. New antimicrobial-coated catheters (chlorhexidine, silver, minocycline-rifampin) (BD, ICU Medical, 2025) reduce CRBSI risk.
- Needlestick injuries (safety-engineered devices) : Needlestick injuries transmit HIV, HBV, HCV. New safety-engineered IV catheters (passive shield, active retractable) (BD, B. Braun, 2025) comply with OSHA and EU Directive.
- Needle-free connectors (infection prevention) : Needle-free connectors reduce needlestick injuries but can harbor bacteria. New antimicrobial needle-free connectors (silver, chlorhexidine) (ICU Medical, 2025) reduce infection risk.
- Closed-system transfer devices (CSTDs) for hazardous drugs (chemotherapy) : Chemotherapy drugs pose exposure risk to healthcare workers. New CSTDs (BD, ICU Medical, 2025) prevent drug leakage, vapor release.
3. Real-World User Cases (2025–2026)
Case A – Hospital (Infusion Set, Indwelling Needle) : Cleveland Clinic (USA) used BD Nexiva closed IV catheter system (indwelling needle) and ICU Medical PlumSet (infusion set) for general IV therapy (2025). Results: (1) safety-engineered (needlestick prevention); (2) closed-system (infection prevention); (3) reliable fluid delivery; (4) reduced CRBSI rates by 50%. “Safety-engineered infusion consumables are essential for infection prevention.”
Case B – Home Infusion (Pharmacy) : Option Care Health (USA) used B. Braun Introcan safety IV catheters and infusion sets for home infusion patients (antibiotics, chemotherapy, hydration) (2026). Results: (1) safety-engineered (patient and caregiver safety); (2) easy to use; (3) reliable infusion; (4) reduced hospital readmissions. “Home infusion consumables enable safe, effective outpatient therapy.”
Strategic Implications for Stakeholders
For hospital procurement directors, infection control professionals, and clinical managers, medical infusion consumables selection depends on: (1) product type (infusion set, syringe, blood transfusion set, blood collection needle, indwelling needle), (2) safety features (needlestick prevention, antimicrobial coating, closed-system), (3) material (PVC, DEHP-free, non-PVC, non-DEHP, latex-free), (4) sterility (sterile, single-use), (5) compatibility (IV pumps, connectors), (6) cost per unit ($0.10-5.00), (7) regulatory compliance (FDA, CE, ISO 13485), (8) infection prevention (CRBSI reduction), (9) environmental sustainability (recyclable materials, reduced packaging), (10) supply chain reliability. For manufacturers, growth opportunities include: (1) safety-engineered IV catheters (needlestick prevention), (2) antimicrobial-coated catheters (CRBSI reduction), (3) needle-free connectors (infection prevention), (4) closed-system transfer devices (CSTDs for hazardous drugs), (5) DEHP-free and non-PVC materials (environmental, health concerns), (6) home infusion consumables (fastest-growing), (7) cost reduction (emerging markets), (8) emerging markets (Asia-Pacific, Latin America, Middle East, Africa), (9) regulatory approvals (FDA, CE, ISO 13485), (10) digital integration (smart infusion systems, IoT).
Conclusion
The medical infusion consumables market is growing at 6.3% CAGR, driven by increasing surgical procedures, chronic diseases, aging population, and needlestick injury prevention regulations. Infusion set (35% share) dominates, with indwelling needle (7% CAGR) fastest-growing. Hospital (70% share) is the largest end-user, with pharmacy (8% CAGR) fastest-growing. Becton Dickinson (BD), Baxter, B. Braun, Fresenius Kabi, ICU Medical, and Chinese manufacturers lead the market. As Global Info Research’s forthcoming report details, the convergence of safety-engineered IV catheters (needlestick prevention) , antimicrobial-coated catheters (CRBSI reduction) , needle-free connectors (infection prevention) , closed-system transfer devices (CSTDs for hazardous drugs) , and home infusion consumables will continue expanding the category as the standard of care for safe, precise drug and fluid delivery.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
